10x Genomics, Inc. - stock earnings
TXG Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| April 30, 2024 AfterMarket | -0.50 / -0.51 | - | 141.0 million / 143.7 million | - |
| Aug. 1, 2024 BeforeMarket | - / - | 149.8 million | - / 157.1 million | 163.7 million |
TXG Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q1 | -59.9 million USD | 141.0 million USD |
| 2023Q4 | -49.0 million USD | 184.0 million USD |
| 2023Q3 | -93.0 million USD | 153.6 million USD |
| 2023Q2 | -62.4 million USD | 146.8 million USD |
| 2023Q1 | -50.7 million USD | 134.3 million USD |
| 2022Q4 | -17.2 million USD | 156.2 million USD |
| 2022Q3 | -41.9 million USD | 131.1 million USD |
| 2022Q2 | -64.5 million USD | 114.6 million USD |
| 2022Q1 | -42.4 million USD | 114.5 million USD |
| 2021Q4 | -18.4 million USD | 143.5 million USD |
| 2021Q3 | -17.2 million USD | 125.3 million USD |
| 2021Q2 | -11.1 million USD | 115.8 million USD |
| 2021Q1 | -11.6 million USD | 105.8 million USD |
| 2020Q4 | -415.6 million USD | 112.2 million USD |
| 2020Q3 | -65.8 million USD | 71.8 million USD |
| 2020Q2 | -40.2 million USD | 42.9 million USD |
| 2020Q1 | -21.1 million USD | 71.9 million USD |
| 2019Q4 | -7.1 million USD | 75.3 million USD |
| 2019Q3 | -9.6 million USD | 61.2 million USD |
| 2019Q2 | -10.9 million USD | 55.8 million USD |
| 2019Q1 | -3.6 million USD | 53.6 million USD |
| 2018Q4 | -75.5 million USD | 50.6 million USD |
| 2018Q3 | -15.3 million USD | 36.6 million USD |
| 2018Q2 | -5.9 million USD | 31.7 million USD |
| 2018Q1 | -10.8 million USD | 29.6 million USD |
TXG Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -255.1 million USD | 618.7 million USD |
| 2022 | -166.0 million USD | 516.4 million USD |
| 2021 | -58.2 million USD | 490.5 million USD |
| 2020 | -542.7 million USD | 298.8 million USD |
| 2019 | -31.3 million USD | 245.9 million USD |
| 2018 | -112.5 million USD | 146.3 million USD |
| 2017 | -18.8 million USD | 71.1 million USD |
TXG
Price: $27.48
52 week price:
Earnings Per Share: -2.18 USD
P/E Ratio: -22.71
Exchange: NMS
Sector: Healthcare
Industry: Health Information Services
Volume: 10738
Market Capitalization: 3.2 billion